|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: SNHG32 |
Gene summary for SNHG32 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | SNHG32 | Gene ID | 50854 |
| Gene name | small nucleolar RNA host gene 32 | |
| Gene Alias | C6orf48 | |
| Cytomap | 6p21.33 | |
| Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 50854 | SNHG32 | P7 | Human | Prostate | Tumor | 1.25e-04 | -4.89e-01 | -0.1025 |
| 50854 | SNHG32 | P9 | Human | Prostate | Tumor | 2.48e-10 | -4.89e-01 | -0.0285 |
| 50854 | SNHG32 | P10 | Human | Prostate | Tumor | 1.50e-11 | -4.89e-01 | -0.0902 |
| 50854 | SNHG32 | GSM5353221_PA_PB2A_Pool_1_3_S25_L001 | Human | Prostate | Tumor | 1.97e-08 | -4.89e-01 | 0.1633 |
| 50854 | SNHG32 | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 1.29e-12 | -4.89e-01 | 0.1608 |
| 50854 | SNHG32 | GSM5353223_PA_PB2B_Pool_2_S26_L001 | Human | Prostate | Tumor | 7.58e-07 | -4.89e-01 | 0.1604 |
| 50854 | SNHG32 | GSM5353224_PA_PR5186_Pool_1_2_3_S27_L001 | Human | Prostate | Tumor | 1.63e-07 | -4.89e-01 | 0.1621 |
| 50854 | SNHG32 | GSM5353225_PA_PR5196-1_Pool_1_2_3_S53_L002 | Human | Prostate | Tumor | 5.01e-03 | -4.89e-01 | 0.1619 |
| 50854 | SNHG32 | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 6.01e-09 | -4.89e-01 | 0.1602 |
| 50854 | SNHG32 | GSM5353236_PA_PR5251_T1_S7_L001 | Human | Prostate | Tumor | 1.80e-03 | -4.89e-01 | 0.1608 |
| 50854 | SNHG32 | GSM5353240_PA_PR5254_T1_S15_L001 | Human | Prostate | Tumor | 8.80e-15 | -4.89e-01 | 0.1575 |
| 50854 | SNHG32 | GSM5353243_PA_PR5261_T1_S23_L002 | Human | Prostate | Tumor | 2.05e-16 | -4.89e-01 | 0.1545 |
| 50854 | SNHG32 | GSM5353244_PA_PR5261_T2_S24_L002 | Human | Prostate | Tumor | 2.90e-12 | -4.89e-01 | 0.1569 |
| 50854 | SNHG32 | P1_S1_AK | Human | Skin | AK | 3.30e-28 | 5.04e-01 | -0.3399 |
| 50854 | SNHG32 | P2_S3_AK | Human | Skin | AK | 6.28e-38 | 6.24e-01 | -0.3287 |
| 50854 | SNHG32 | P2_S4_SCCIS | Human | Skin | SCCIS | 8.14e-13 | 4.18e-01 | -0.3043 |
| 50854 | SNHG32 | P3_S6_AK | Human | Skin | AK | 4.59e-09 | 2.80e-01 | -0.3256 |
| 50854 | SNHG32 | P4_S8_cSCC | Human | Skin | cSCC | 3.13e-25 | 4.60e-01 | -0.3095 |
| 50854 | SNHG32 | P5_S10_cSCC | Human | Skin | cSCC | 5.40e-24 | 3.36e-01 | -0.299 |
| 50854 | SNHG32 | Pat01-B | Human | Stomach | GC | 1.46e-03 | 1.34e-01 | 0.5754 |
| Page: 1 2 3 4 5 6 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Cervix |  | CC: Cervix cancer |
| HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions | ||
| N_HPV: HPV-infected normal cervix | ||
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| GC |  | CAG: Chronic atrophic gastritis |
| CAG with IM: Chronic atrophic gastritis with intestinal metaplasia | ||
| CSG: Chronic superficial gastritis | ||
| GC: Gastric cancer | ||
| SIM: Severe intestinal metaplasia | ||
| WIM: Wild intestinal metaplasia | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |